|
Market Closed -
OTC Markets
20:37:32 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.5000 USD | +11.11% |
|
+11.11% | +11.11% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.87M 1.76M 1.6M 3.02M 208M 3.03M 20.85M 8.13M 105M 8.17M 7.99M 348M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.62M 10.89M 9.94M 18.73M 1.29B 18.79M 129M 50.42M 650M 50.62M 49.52M 2.16B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Cyanotech Corporation
| 1 day | +11.11% | ||
| 1 week | +11.11% | ||
| Current month | -5.62% | ||
| 1 month | -5.62% | ||
| 3 months | +35.14% | ||
| 6 months | +16.28% | ||
| Current year | +11.11% |
| 1 week | 0.35 |  | 0.53 |
| 1 month | 0.35 | | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.23 | | 0.57 |
| 3 years | 0.12 | | 1.02 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 15/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 30/03/2016 |
| Director of Finance/CFO | 46 | 20/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 26/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 16/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 15/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +11.11% | +11.11% | +47.06% | -20.65% | 3.62M | |
| -0.13% | -6.44% | +60.34% | +114.35% | 1,047B | |
| +0.85% | -0.81% | +51.29% | +63.71% | 646B | |
| -1.03% | -3.58% | +21.43% | +72.25% | 451B | |
| -1.46% | -4.50% | +37.80% | +37.01% | 355B | |
| -0.72% | -2.89% | +22.32% | +37.60% | 291B | |
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | |
| -1.05% | -1.57% | +50.30% | +67.68% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.11% | 203B | |
| -2.14% | -0.30% | +28.95% | +87.59% | 181B | |
| Average | +0.43% | -2.41% | +30.34% | +41.69% | 365.93B | |
| Weighted average by Cap. | -0.46% | -3.46% | +38.17% | +65.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 19.88M 18.64M 17.02M 32.05M 2.2B 32.16M 221M 86.28M 1.11B 86.62M 84.74M 3.69B | 24.22M 20.87M 19.56M 17.86M 33.64M 2.31B 33.75M 232M 90.56M 1.17B 90.92M 88.94M 3.87B |
| Net income | -5.27M -4.54M -4.26M -3.88M -7.32M -503M -7.34M -50.49M -19.7M -254M -19.77M -19.34M -843M | -3.2M -2.76M -2.59M -2.36M -4.45M -306M -4.46M -30.7M -11.98M -155M -12.03M -11.76M -512M |
| Net Debt | 10.2M 8.79M 8.24M 7.52M 14.17M 975M 14.21M 97.74M 38.14M 492M 38.28M 37.45M 1.63B | 11.31M 9.74M 9.14M 8.34M 15.71M 1.08B 15.76M 108M 42.29M 546M 42.45M 41.53M 1.81B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | US$0.5000 | +11.11% | 50,500 |
| 26/08/26 | US$0.4500 | 0.00% | 500 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
